Cognex Co. (CGNX) Holdings Increased by Parametric Portfolio Associates LLC

Parametric Portfolio Associates LLC raised its holdings in shares of Cognex Co. (NASDAQ:CGNX) by 19.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 124,168 shares of the scientific and technical instruments company’s stock after purchasing an additional 20,615 shares during the period. Parametric Portfolio Associates LLC owned approximately 0.07% of Cognex worth $13,693,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of CGNX. Schwab Charles Investment Management Inc. boosted its stake in Cognex by 0.8% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 392,145 shares of the scientific and technical instruments company’s stock valued at $33,294,000 after purchasing an additional 3,093 shares during the last quarter. Legal & General Group Plc boosted its stake in Cognex by 24.0% during the 2nd quarter. Legal & General Group Plc now owns 65,867 shares of the scientific and technical instruments company’s stock valued at $5,592,000 after purchasing an additional 12,734 shares during the last quarter. Victory Capital Management Inc. boosted its stake in Cognex by 21.2% during the 2nd quarter. Victory Capital Management Inc. now owns 15,292 shares of the scientific and technical instruments company’s stock valued at $1,298,000 after purchasing an additional 2,672 shares during the last quarter. Airain ltd purchased a new stake in Cognex during the 2nd quarter valued at $1,074,000. Finally, Utah Retirement Systems boosted its stake in Cognex by 2.7% during the 2nd quarter. Utah Retirement Systems now owns 15,200 shares of the scientific and technical instruments company’s stock valued at $1,290,000 after purchasing an additional 400 shares during the last quarter. Institutional investors and hedge funds own 42.10% of the company’s stock.

In related news, Director Patrick Alias sold 5,000 shares of the firm’s stock in a transaction on Monday, November 27th. The stock was sold at an average price of $143.54, for a total value of $717,700.00. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Jeffrey Benjamin Miller sold 7,500 shares of the firm’s stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $124.23, for a total value of $931,725.00. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 143,750 shares of company stock worth $18,540,975. 5.60% of the stock is owned by insiders.

Several research firms have recently weighed in on CGNX. Zacks Investment Research cut Cognex from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 3rd. JPMorgan Chase & Co. cut Cognex from a “neutral” rating to an “underweight” rating and set a $62.50 price target on the stock. in a report on Wednesday, November 8th. Robert W. Baird increased their price target on Cognex from $50.00 to $62.00 and gave the company a “neutral” rating in a report on Tuesday, October 31st. BidaskClub cut Cognex from a “buy” rating to a “hold” rating in a report on Thursday, December 7th. Finally, Canaccord Genuity increased their price target on Cognex from $47.50 to $60.00 and gave the company a “hold” rating in a report on Tuesday, October 31st. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and five have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $60.17.

Cognex Co. (CGNX) opened at $61.16 on Monday. The firm has a market capitalization of $10,591.26, a price-to-earnings ratio of 45.14 and a beta of 1.50. Cognex Co. has a twelve month low of $31.18 and a twelve month high of $72.99.

Cognex (NASDAQ:CGNX) last released its quarterly earnings results on Monday, October 30th. The scientific and technical instruments company reported $0.57 earnings per share for the quarter, beating the consensus estimate of $0.52 by $0.05. The firm had revenue of $259.74 million for the quarter, compared to analysts’ expectations of $255.95 million. Cognex had a return on equity of 23.31% and a net margin of 34.77%. The company’s revenue was up 75.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.31 EPS. equities analysts anticipate that Cognex Co. will post 1.39 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This piece was first published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this piece on another site, it was copied illegally and reposted in violation of international copyright law. The correct version of this piece can be viewed at https://www.chaffeybreeze.com/2018/01/01/cognex-co-cgnx-holdings-increased-by-parametric-portfolio-associates-llc.html.

Cognex Profile

Cognex Corporation (Cognex) is a provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. The Company operates through the machine vision technology segment. The Company’s machine vision products are used to automate the manufacture and tracking of discrete items, such as mobile phones, aspirin bottles and automobile tires, by locating, identifying, inspecting and measuring them during the manufacturing or distribution process.

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Co. (NASDAQ:CGNX).

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply